18 Members•4,119 Posts

Health

Custom Health CEO discusses US expansion after TSX debut - ICYMI

Jul 4, 2026

Emily Jarvie

Imugene reports second BTKi cohort response - ICYMI

Jul 4, 2026

Jonathan Jackson

Delivra Health Brands launches LivRelief Itch Cream - ICYMI

Jul 4, 2026

Emily Jarvie

SMALL-CAP MOVERS: AIM gets the summer fundraising bug as investors back helium, batteries and weight-loss pills

Jul 3, 2026

Ian Lyall

Orthocell expands Remplir reach with exclusive Thailand distributor

Jul 3, 2026

Jonathan Jackson

Custom Health quarterly revenue rises thanks to InnovativeRx deal

Jul 3, 2026

Angela Harmantas

Custom Health targets U.S. growth with connected pharmacy platform and TSX debut

Jul 2, 2026

Steve Darling

Imugene CEO details azer-cel trial milestone - ICYMI

Jul 2, 2026

Jonathan Jackson

Delivra Health Brands launches LivRelief Itch Cream for Eczema, Psoriasis and Sensitive Skin Relief

Jul 2, 2026

Steve Darling

Delivra Health launches LivRelief Itch Relief Cream in Canada

Jul 2, 2026

Emily Jarvie

Imugene CEO on Phase 1b azer-cel data: second complete response

Jul 2, 2026

Kerry Stevenson

Imugene reports second complete response in azer-cel BTKi cohort

Jul 1, 2026

Jonathan Jackson

Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones

Jul 1, 2026

Jonathan Jackson

EMV Capital to deconsolidate Glycotest and ProAxsis after fundraisings

Jul 1, 2026

Ian Lyall

Abivax shares jump as updated trial data eases safety concerns

Jun 30, 2026

Emily Jarvie

Imugene reports first complete response in azer-cel BTKi cohort

Jun 30, 2026

Jonathan Jackson

Merck, AbbVie probed by US lawmakers over China clinical trials: report

Jun 30, 2026

Emily Jarvie

Peak Processing expands into US THC beverage market with Fryday Kush deal

Jun 30, 2026

Jonathan Jackson

Orthocell expands Remplir humanitarian program in Ukraine after battlefield trauma use

Jun 30, 2026

Ephrem Joseph

Poolbeg Pharma secures South African patent for lead drug candidate - UPDATE

Jun 30, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy